Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies Simendra SinghAlok K. Gupta Mini Review 05 May 2011 Pages: 1211 - 1224
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies Paula M. FracassoKerry J. WilliamsHelen Piwnica-Worms Original Article Open access 08 August 2010 Pages: 1225 - 1237
A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC Athanasios G. PallisVassilis ChandrinosVassilis Georgoulias Original Article 10 August 2010 Pages: 1239 - 1245
A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) and satraplatin (OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum(IV) Petr SovaAdolf MistrJaroslav Chládek Original Article 10 August 2010 Pages: 1247 - 1256
Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer Yen-Shen LuDar-Ren ChenChiun-Sheng Huang Original Article 11 August 2010 Pages: 1257 - 1263
A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy Ken KatoMakoto TaharaTaku Seriu Original Article 12 August 2010 Pages: 1265 - 1272
Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101) N. L. SteeleJ. A. PlumbT. R. J. Evans Original Article 13 August 2010 Pages: 1273 - 1279
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan Jen-Shi ChenYee ChaoJacqueline Whang-Peng Original Article 17 August 2010 Pages: 1281 - 1289
Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model Meredith K. ChukDiane E. ColeElizabeth Fox Original Article 20 August 2010 Pages: 1291 - 1297
Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance Murugan KalimuthoAntonella MinutoloSergio Bernardini Original Article 24 August 2010 Pages: 1299 - 1312
Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant S. Aubrey StochCynthia GarganoHoward E. Greenberg Original Article 24 August 2010 Pages: 1313 - 1321
Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis Junshik HongSae-Won HanTae-You Kim Original Article 24 August 2010 Pages: 1323 - 1331
Detection of doxorubicin hydrochloride accumulation in the rat brain after morphine treatment by mass spectrometry Iacopo SardiGiancarlo la MarcaMaurizio Aricò Original Article 25 August 2010 Pages: 1333 - 1340
Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator Linda RauschCarol GreenJon Mirsalis Original Article 25 August 2010 Pages: 1341 - 1352
NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer Johanna HilliLiisa SailasKari Laine Original Article 27 August 2010 Pages: 1353 - 1362
Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer Chikara KunisakiMasazumi TakahashiItaru Endo Original Article 28 August 2010 Pages: 1363 - 1368
p53-dependent anticancer effects of leptomycin B on lung adenocarcinoma Changxia ShaoChuanwen LuWeimin Gao Original Article 28 August 2010 Pages: 1369 - 1380
Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation Heiko BuggerCinthia GuzmanRaymond R. Russell III Original Article 31 August 2010 Pages: 1381 - 1388
Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin Chi-Hui TangChristi ParhamNeela Patel Original Article Open access 31 August 2010 Pages: 1389 - 1400
Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor Edi LeviLiyue ZhangArun K. Rishi Original Article 31 August 2010 Pages: 1401 - 1413
Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models Idoia GamezRobert P. RyanBeth A. Hollister Original Article 31 August 2010 Pages: 1415 - 1422
Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer D. TakahariT. HamaguchiM. Sasako Original Article 01 September 2010 Pages: 1423 - 1428
A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer Masashi KanaiKenichi YoshimuraEtsuro Hatano Original Article 02 September 2010 Pages: 1429 - 1434
Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer Yoon-Koo KangMin-Hee RyuTae Won Kim Original Article 02 September 2010 Pages: 1435 - 1443
Interleukin-1 receptor antagonist attenuates cyclophosphamide-induced mucositis in a murine model Di XiangYiping GuoWei Han Original Article 03 September 2010 Pages: 1445 - 1453
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients Carlo BuonerbaPiera FedericoGiuseppe Di Lorenzo Clinical Trial Report 02 March 2011 Pages: 1455 - 1461
Erratum to: Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients Carlo BuonerbaPiera FedericoGiuseppe Di Lorenzo Erratum 30 March 2011 Pages: 1463 - 1463
Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy Takeshi MasudaNoboru HattoriNobuoki Kohno Short Communication 28 January 2011 Pages: 1465 - 1469
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients Sin-Chi ChewOnkar SinghBalram Chowbay Short Communication 06 April 2011 Pages: 1471 - 1478
Estimating the correct way of calculating the carboplatin dose Jesús F. Sierra-SánchezTriana González-Carrascosa Letter to the Editor 20 March 2011 Pages: 1479 - 1480
Prospectives and limitations by a novel algorithm Karin HolwegerHans-Peter Lipp Reply to the Letter 20 March 2011 Pages: 1481 - 1482